Cite
HARVARD Citation
Pan, L. et al. (2020). A novel danshensu derivative ameliorates experimental colitis by modulating NADPH oxidase 4‐dependent NLRP3 inflammasome activation. Journal of cellular and molecular medicine. 24 (22), pp. 12955-12969. [Online].